摘要

1文献来源Mittendorf EA,Zhang H,Barrios C H,et al.Neoadjuvant atezolizumab in combination withsequential nab-paclitaxel and anthracycline-basedchemotherapy versus placebo and chemotherapy in patients with early stage triple-negative breast cancer(IMpassion031):A randomized,double-blind,phase3 trial[J]. Lancet,2020,396(10257):1090-1100.2证据水平